Dupilumab Safe, Effective for Atopic Dermatitis in Real-Life Settings
In 2017, dupilumab became the first treatment approved in Canada for moderate to severe AD, as multiple clinical trials demonstrated its effectiveness and safety.
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
Disparities in Digital Health Portal Use Persist Beyond the COVID-19 Pandemic
Although the pandemic spurred a greater need and use of online health resources, certain demographics continue to report significantly low participation in digital health portals.
The Importance of Continuing Education in Pharmacy Compounding
Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.
Small Doses: February 26 to March 1
Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.
FDA Approves Amivantamab-vmjw for Locally Advanced, Metastatic NSCLC With EGFR Exon 20 Insertion Mutation
The FDA granted accelerated approval to amivantamab-vmjw in May 2021.
2 Commerce Drive Cranbury, NJ 08512